Health Industry Embraces Monetary Incentive Program for Prescriptions
A new program, which provides a monetary incentive to patients to take their medication, is being studied in Philadelphia.
U.S. GAO warns consumers that herbal supplements tout false benefits
One of the biggest risks to consumers is when they are told that herbal supplements can replace their prescription meds.
If patients would take prescriptions as directed, the U.S. would save billions in health costs
So say U.S. researchers after conducting a study.
U.S. Senator asks drugmakers to explain high prices
Some Democrats have attacked drugmakers as the U.S. Congress works on an overhaul of U.S. healthcare system, reports Reuters.
Did you know…
…that the more you worry about a new medication, the more likely you are to experience side effects?
Drugmakers are starting to use gadget technology to improve outcomes and prove effectiveness
Johnson & Johnson, for example, has created an iPhone app for diabetic patients.
As healthcare reform looms, drug makers raising prices
But drug companies say they are having to raise prices to maintain the profits necessary to invest in research and development of new drugs as the patents on many of their most popular drugs are set to expire over the next few years, reports the New York Times.
AARP: Consumers should switch to generic drugs wherever possible
Generic drugs prices are falling, but many consumers are taking their more expensive counterparts.
FDA chief says the agency will speed up drug inspections and warnings
One of the chief’s decisions is that the FDA will no longer require all warning letters be reviewed by the agency’s top lawyer before being sent to manufacturers.
Finding a cure for lupus
Today, the Human Genome Sciences will announce the results from a clinical trial testing Benlysta. This drug has been found to be effective in curing lupus, an autoimmune disease found mostly in women under the age of 40.